ANDA 70949, held by Morton Grove Pharmaceuticals. Metoclopramide Hydrochloride.
As of Nov 21, 2026, ANDA 70949 (Metoclopramide Hydrochloride), held by Morton Grove Pharmaceuticals, was first approved by FDA on Jun 28, 1993, with 7 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 28, 1993 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Metoclopramide HydrochlorideEQ 5MG BASE/5ML · solution;oral | Metoclopramide Hydrochloride | Discontinued |
| Mar 1, 1996 | Supplement 11Labeling | Approved | None posted |
| Nov 24, 1993 | Supplement 10Labeling | Approved | None posted |
| Jun 28, 1993 | Original application | Approved | None posted |
| Jun 8, 1993 | Supplement 9Labeling | Approved | None posted |
| Nov 7, 1991 | Supplement 6Labeling | Approved | None posted |
| May 31, 1991 | Supplement 8Labeling | Approved | None posted |
| Mar 19, 1991 | Supplement 7Labeling | Approved | None posted |
| May 25, 1989 | Supplement 5Labeling | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters